Tonix Pharmaceuticals announced data on their TNX-1900 product candidate for treating chronic migraine at a conference, supporting its proposed mechanism of action.
AI Assistant
TONIX PHARMACEUTICALS HOLDING CORP
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.